Fig. 1.

Figure presents number of recommendations made by clinical pharmacists, and number of recommendations accepted by the attending physician, during the study period according to five categories: recommendations to consider discontinuing concomitant antiplatelet therapy, decrease dose, increase dose, monitoring the plasma level of the anticoagulant (TDM), and “other” recommendations